Interestingly, Kristiansen et al. suggested PPARγ as a prognostic marker for pancreatic cancer as they found strong PPARγ expression in pancreatic ductal adenocarcinoma with shorter patients’ survival times. This evidence concerns the gene PPARG and pancreatic ductal adenocarcinoma.